Focus: University spin-outs
The Fund presents the opportunity for alumni and qualifying investors to make an impact investment in spin-out companies formed to commercialise scientific and technological advances made at Queen’s University Belfast. To support the Fund’s pipeline, consideration will also be given to Queen’s student ventures and spin-outs from partner Universities participating in the Queen’s administered NxNW ICURe Programme. The NxNW consortium encompasses Ulster University, University of Edinburgh, University of Liverpool, University of Sheffield, University of Manchester, and the University of Leeds.
Liopa spun out of Queen’s University Belfast in 2016. The company is onward developing and commercialising research carried out within the university into Visual Speech Recognition (VSR), effectively automated lip reading.
Fusion Antibodies is dedicated to the discovery and early development of antibodies to help bring about a positive change in the healthcare industry.
CV6 Therapeutics is dedicated to the development of novel innovative therapeutics to improve the lives of patients with cancer and inflammatory diseases.
We are here to help you get started.